
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Dallas - Most community-acquired methicillin-resistant staphylococcus aureus (MRSA) skin and soft tissue abscesses smaller than 5 cm can be managed with standard incision and drainage, without the need for antibiotic therapy, according to a new study.






